Foliar Epidermal Morphology and Anti-diabetic Property of Andrographis paniculata (Burm. f.) Wall ex. Nees

The leaf epidermal features and anti diabetic property of Androgragphis paniculata were investigated. The epidermal cells are polygonal to irregular with curved to undulate anticlinal walls on both surfaces of the leaf. The leaf is hypostomatic with stomata restricted to the abaxial surface. Stomata type is axillocytic. The epidermal cells contain deposits of crystal oxalates while cystoliths are found in a few cells. The leaf extract was evaluated for hypoglycemic effects. There was significant hypoglycemic effect in alloxan induced diabetic rats following administration of the leaf aqueous extract. The result shows that the level of fasting blood sugar was dependent on the previous level of basal blood sugar in the four groups of rats used for this study. Treatment of the rats with A. paniculata showed a dose dependent relationship with the time it took for the blood of the rats to return to the basal blood sugar levels. The study supports the use of the plant in the management and treatment of diabetes

The Antimicrobial Potential and Phytochemical Composition of Aristolochia Ringens VAHL

Aristolochia ringens, a plant called Ako-igun in Yoruba, is widely distributed in southwestern Nigeria. Traditionally, it is used for the treatment of cancerous sore, lung inflammation, dysentery and dermatitis. The antimicrobial activity of A. ringens was tested on six pathogenic bacteria viz., Shigella sonnei, Salmonella typhii, Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Proteus mirabilis and five fungi viz., Fusarium sp, Sporotrichum sp, Pichia sp, Penicillium camemberti and Aspergillus niger.Extracts from powdered stem and root barks of A. ringens were prepared using sterile water, ethanol, petroleum ether and acetone. The extracts were tested on each of the pathogens for their antimicrobial properties. The stem and the root barks were also screened for presence of secondary metabolites following standard procedures.The aqueous extracts of the stem and the root barks were not effective against all the bacteria and fungi tested except Shigella sonnei with Minimum Inhibitory Concentration (MIC) of 40mg/ml. Petroleum ether extracts of the stem and root barks were equally not active against all the bacteria isolates used but the root bark extracts reacted effectively against the fungal isolates, showing good potency at 40mg/ml. Ethanol extract of the stem bark was very potent against all the bacteria isolates at MIC of 33.3mg/ml except Shigella sonnei while the root bark ethanol extract only showed little effectiveness against the fungi. A similar result was obtained when acetone was used as solvent of extraction. Comparatively, ethanol and acetone stem and root bark extracts were less potent on the fungi isolates than the petroleum ether extract. The plant parts studied showed the presence of alkaloids, flavonoids, tannins, terpenoids and cardiac glycosides.Thus, the root and stem bark extracts from Aristolochia ringens may be broad based in their antimicrobial activities. The extracts, if purified and crystallized, may serve as alternatives to antimicrobial drugs. Keywords: Aristolochia ringens, Microorganisms, Ethnomedicine, Phytochemicals, Plant extract

Foliar Epidermal Morphology and Anti-diabetic Property of Andrographis paniculata (Burm. f.)Wall ex. Nees

Abstract The leaf epidermal features and anti diabetic property of Androgragphis paniculata were investigated. The epidermal cells are polygonal to irregular with curved to undulate anticlinal walls on both surfaces of the leaf. The leaf is hypostomatic with stomata restricted to the abaxial surface. Stomata type is axillocytic. The epidermal cells contain deposits of crystal oxalates while cystoliths are found in a few cells. The leaf extract was evaluated for hypoglycemic effects. There was significant hypoglycemic effect in alloxan induced diabetic rats following administration of the leaf aqueous extract. The result shows that the level of fasting blood sugar was dependent on the previous level of basal blood sugar in the four groups of rats used for this study. Treatment of the rats with A. paniculata showed a dose dependent relationship with the time it took for the blood of the rats to return to the basal blood sugar levels. The study supports the use of the plant in the management and treatment of diabetes

Conformational switch and multiple supramolecular structures of a newly identified self-assembling protein-mimetic peptide from Pseudomonas aeruginosa YeaZ protein

Protein-mimetic peptides (PMPs) are shorter sequences of self-assembling proteins, that represent remarkable building blocks for the generation of bioinspired functional supramolecular structures with multiple applications. The identification of novel aminoacidic sequences that permit the access to valuable biocompatible materials is an attractive area of research. In this work, in silico analysis of the Pseudomonas aeruginosa YeaZ protein (PaYeaZ) led to the identification of a tetradecapeptide that represents the shortest sequence responsible for the YeaZ-YeaZ dimer formation. Based on its sequence, an innovative 20-meric peptide, called PMP-2, was designed, synthesized, and characterized in terms of secondary structure and self-assembly properties. PMP-2 conserves a helical character and self-assembles into helical nanofibers in non-polar solvents (DMSO and trifluoroethanol), as well as in dilute (0.5 mM) aqueous solutions. In contrast, at higher concentrations (> 2 mM) in water, a conformational transition from alpha-helix to beta-sheet occurs, which is accompanied by the Protein-mimetic peptide aggregation into 2D-sheets and formation supramolecular gel in aqueous environment. Our findings reveal a newly identified Protein-mimetic peptide that could turn as a promising candidate for future material applications

Cellular and Molecular Signatures of Oxidative Stress in Bronchial Epithelial Cell Models Injured by Cigarette Smoke Extract

Exposure of the airways epithelium to environmental insults, including cigarette smoke, results in increased oxidative stress due to unbalance between oxidants and antioxidants in favor of oxidants. Oxidative stress is a feature of inflammation and promotes the progression of chronic lung diseases, including Chronic Obstructive Pulmonary Disease (COPD). Increased oxidative stress leads to exhaustion of antioxidant defenses, alterations in autophagy/mitophagy and cell survival regulatory mechanisms, thus promoting cell senescence. All these events are amplified by the increase of inflammation driven by oxidative stress. Several models of bronchial epithelial cells are used to study the molecular mechanisms and the cellular functions altered by cigarette smoke extract (CSE) exposure, and to test the efficacy of molecules with antioxidant properties. This review offers a comprehensive synthesis of human in-vitro and ex-vivo studies published from 2011 to 2021 describing the molecular and cellular mechanisms evoked by CSE exposure in bronchial epithelial cells, the most used experimental models and the mechanisms of action of cellular antioxidants systems as well as natural and synthetic antioxidant compounds

KRAS status and risk of venous thromboembolic events in patients with metastatic colorectal cancer: a case-control study.

No abstract availabl

The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer

Background: Emerging data suggest that gender-related immune system composition affects both immune response and efficacy of immunotherapy in cancer patients (pts). This study aimed to investigate the sex-related prognostic role of MLR in metastatic colorectal cancer (mCRC) pts. Methods: We analyzed a retrospective consecutive cohort of 490 mCRC patients treated from 2009 to 2018 at the Oncology Departments of Aviano and Pordenone (training set) and Udine (validation set), Italy. The prognostic impact of MLR on overall survival (OS) was evaluated with uni- and multivariable Cox regression models. The best cut-off value to predict survival was defined through ROC analyses. Results: Overall, we identified 288 males (59%) and 202 females (41%); 161 patients (33%) had a right-sided, 202 (42%) a left-sided primary, and 122 (25%) a rectal tumor. Interestingly, gender was associated with MLR (p = 0.004) and sidedness (p = 0.006). The obtained cut-off value for MLR in females and males was 0.27 and 0.49, respectively. According to univariate analysis of the training set, MLR (HR 9.07, p ≤ 0.001), MLR > 0.27 in females (HR 1.95, p = 0.003), and MLR > 0.49 in males (HR 2.65, p = 0.010) were associated with poorer OS, which was also confirmed in the validation set. In multivariate analysis, MLR > 0.27 in females (HR 2.77, p = 0.002), MLR > 0.49 in males (HR 5.39, p ≤ 0.001), BRAF mutation (HR 3.38, p ≤ 0.001), and peritoneal metastases (HR 2.50, p = 0.003) were still independently associated with worse OS. Conclusions: Males and females have a different immune response. Our study showed that high MLR, both in males and females, is an unfavorable Independent prognostic factor. Further prospective studies are needed to confirm these data

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC

Background: Programmed cell death 1 (PD-1) and PD-ligand 1 (PD-L1) inhibitors represent novel therapeutic options for advanced non-small cell lung cancer (NSCLC). However, approximately 50% of patients do not benefit from therapy and experience rapid disease progression. PD-L1 expression is the only approved biomarker of benefit to anti-PD-1/PD-L1 therapy. However, its weakness has been evidenced in many studies. More recently, tumor mutational burden (TMB) has proved to be a suitable biomarker, but its calculation is difficult to obtain for all patients. Methods: We tested specific NSCLC genetic alterations as potential immunotherapy biomarkers. Tumor DNA was obtained from advanced NSCLC patients treated with anti-PD-1 monoclonal antibody nivolumab (n = 44) or pembrolizumab (n = 3). The mutational status of 22 genes was assessed by targeted next-generation sequencing and the association with survival was tested in uni- and multivariate models. The association between gene mutations and clinical benefit was also investigated. Results: The most frequently mutated genes were TP53 (49%), KRAS (43%), ERBB2 (13%), SMAD4 (13%), DDR2 (13%), STK11 (9%), ERBB4 (6%), EGFR (6%), BRAF (6%), and MET (6%). We confirmed that KRASmut patients have a better response to PD-1 inhibitors, showing a longer progression-free survival (PFS) and overall survival (OS) than KRASwt patients. In addition, we observed that patients with ERBB-family mutations, including EGFR, ERBB2, and ERBB4 all failed to respond to PD-1 antibodies, independently of KRAS status. Conclusions: This study suggests that the analysis of KRAS and ERBB-family gene mutational status is valuable when assessing the clinical practice for the selection of NSCLC patients to treat with PD-1 inhibitors

53pimmune related adverse events correlate with clinical outcomes in non small cell lung cancer nsclc patients treated with nivolumab in the italian expanded access programme

n/